Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ViiMed
AddedFeb 15, 2024
UpdatedJun 18, 2026
ViiMed

ViiMed

Series A

ViiMed: A SaaS-based healthcare IT firm, simplifying health system challenges with user-friendly solutions.

HQ
Washington, D.C., DC, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

ViiMed, founded as a healthcare IT company, is dedicated to addressing health system challenges through user-friendly, SaaS-based solutions. The company's core mission is to simplify and enhance care delivery workflows using its no-code platform, which allows for rapid deployment and configuration of clinical documentation, virtual care, and patient engagement processes. ViiMed's offerings cater primarily to enterprise healthcare organizations seeking efficient and scalable IT solutions.

Notable individuals affiliated with ViiMed include key industry experts and healthcare IT innovators who have contributed to the company's growth and technological advancements. ViiMed has garnered attention from investors focused on health tech innovation. The company has achieved significant milestones in extending care delivery to the edge, enhancing patient care through AI and no-code solutions, and improving overall healthcare system efficiency. Its impact is evident in the streamlined operations and improved patient outcomes experienced by its clients.

ViiMed - Similar Companies

viihealth logo

viihealth

viihealth.com

Vi logo

Vi

vi.co

Vivon logo

Vivon

Health Vector logo

Health Vector

healthvector.world

HealthBridgeHQ logo

HealthBridgeHQ

healthbridgehq.com

RxVantage logo

RxVantage

rxvantage.com

GetDoctor logo

GetDoctor

getdoctor.co

Doctivity Health logo

Doctivity Health

J2 Health logo

J2 Health

j2health.com

Notable Health logo

Notable Health

notablehealth.com

VirtualHealth logo

VirtualHealth

virtualhealth.com

Medstreaming logo

Medstreaming

medstreaming.com

NavisHealth logo

NavisHealth

Aihcon logo

Aihcon

aihcon.com

MedClimate logo

MedClimate

ViiMed - Quick Facts

Who are ViiMed's competitors?

Companies similar to ViiMed include viihealth, Vi, Vivon and Health Vector.

When was ViiMed founded?

ViiMed was founded in 2019.

Where is ViiMed's headquarters located?

ViiMed's headquarters is located in Washington, D.C., DC, US.

When was ViiMed's last funding round?

ViiMed's most recent funding round was for $5M (USD) in June 2016.

How much has ViiMed raised to-date?

As of Jun 3, 2016, ViiMed has raised a total of $7.4M (USD).

How many employees does ViiMed have?

ViiMed has 16 employees as of Feb 4, 2024.

ViiMed - Classification

Ownership
  • Private
Technology
  • AI
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Healthcare
Tags
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software